💊 Anuh Pharma Secures Key Approval 🌍

ANUHPHR

Anuh Pharma Ltd has been granted a Certificate of Suitability (CEP) from EDQM for Sulfadimethoxine, an important API used in pharmaceutical formulations. Why this is significant 👇 • Enables broader access to highly regulated international markets • Strengthens global compliance & customer confidence • Opens opportunities for export growth in specialty APIs 📌 Listed stock to watch: Anuh Pharma Ltd — approval could improve long-term visibility & demand outlook. Indian API manufacturers continue gaining global traction. 🚀🇮🇳